Published trade mark details for 2707424

This information was published on 2026-10-27T17:19:29 for IP Right Acceptance Published.

Field	Value
(210)	2707424
(220)	21 Oct 2026
(300)	US, 24 Apr 2026, 99784527
(511) (510)	Class 5 Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, Alzheimer�s, autism and musculoskeletal and skin disease; Antivirals; Antibodies for medical purposes; Biological preparations for the treatment of cancer; Anticoagulants; Stem cells for medical purposes; Radiopharmaceutical preparations for the treatment of cancer and solid tumors; Diagnostic radiopharmaceutical preparations; Diagnostic preparations for medical purposes.
(540)
(550)	Figurative
(730)	Bristol-Myers Squibb Company
(750)	Spruson & Ferguson

 

Find out more about publications on the About page.